| Product Code: ETC6188186 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Shubham Deep | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
The retail pharmacy market in Australia is mature but evolving with the inclusion of value-added services such as health consultations, vaccinations, and chronic disease management. Major pharmacy chains are investing in digital health solutions and home delivery services.
The retail pharmacy sector in Australia is undergoing a transformation fueled by increased consumer expectations, digital health trends, and expansion of pharmacy-led health services. Pharmacies are diversifying their services to include vaccinations, health screenings, and chronic disease management. E-commerce and home delivery of prescription drugs are also rising trends, supported by growing investment in digital platforms and mobile apps.
The retail pharmacy sector contends with pricing pressure due to government-imposed price caps under the PBS. Intense competition from discount chains and online pharmacies is eroding traditional margins. Additionally, workforce shortages and the rising demand for value-added clinical services over simple dispensing are straining operational capacities.
The retail pharmacy market in Australia is heavily influenced by PBS pricing structures and location rules. However, policies allowing corporate pharmacy ownership and the integration of professional services have created space for private equity and chain-store investment, particularly in urban and suburban centers.
The retail pharmacy sector is closely regulated by government policies that control medicine pricing, ownership laws, and dispensing rights. The PBS is a key influence, setting uniform prices across retail pharmacies. Additionally, regulations require that pharmacies be owned by registered pharmacists, limiting corporate entry and maintaining professional oversight. The government also incentivizes pharmacies to offer professional services like medication reviews and health screenings.
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Australia Pharmacy Retail Market Overview |
3.1 Australia Country Macro Economic Indicators |
3.2 Australia Pharmacy Retail Market Revenues & Volume, 2021 & 2031F |
3.3 Australia Pharmacy Retail Market - Industry Life Cycle |
3.4 Australia Pharmacy Retail Market - Porter's Five Forces |
3.5 Australia Pharmacy Retail Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.6 Australia Pharmacy Retail Market Revenues & Volume Share, By Drug Type, 2021 & 2031F |
3.7 Australia Pharmacy Retail Market Revenues & Volume Share, By End User, 2021 & 2031F |
4 Australia Pharmacy Retail Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing demand for healthcare services in Australia |
4.2.2 Growing aging population leading to higher need for pharmaceutical products |
4.2.3 Expansion of pharmacy services to include wellness and preventive care |
4.3 Market Restraints |
4.3.1 Stringent regulations and compliance requirements in the pharmacy sector |
4.3.2 Rising operational costs impacting profit margins |
4.3.3 Competition from online pharmacies and retail chains |
5 Australia Pharmacy Retail Market Trends |
6 Australia Pharmacy Retail Market, By Types |
6.1 Australia Pharmacy Retail Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 Australia Pharmacy Retail Market Revenues & Volume, By Type, 2021- 2031F |
6.1.3 Australia Pharmacy Retail Market Revenues & Volume, By Online, 2021- 2031F |
6.1.4 Australia Pharmacy Retail Market Revenues & Volume, By Offline, 2021- 2031F |
6.2 Australia Pharmacy Retail Market, By Drug Type |
6.2.1 Overview and Analysis |
6.2.2 Australia Pharmacy Retail Market Revenues & Volume, By Generic, 2021- 2031F |
6.2.3 Australia Pharmacy Retail Market Revenues & Volume, By Over the counter (OTC), 2021- 2031F |
6.2.4 Australia Pharmacy Retail Market Revenues & Volume, By Patented, 2021- 2031F |
6.3 Australia Pharmacy Retail Market, By End User |
6.3.1 Overview and Analysis |
6.3.2 Australia Pharmacy Retail Market Revenues & Volume, By Equipment retail, 2021- 2031F |
6.3.3 Australia Pharmacy Retail Market Revenues & Volume, By Drug retail, 2021- 2031F |
6.3.4 Australia Pharmacy Retail Market Revenues & Volume, By Health products retail, 2021- 2031F |
6.3.5 Australia Pharmacy Retail Market Revenues & Volume, By Chemical medicine retail, 2021- 2031F |
6.3.6 Australia Pharmacy Retail Market Revenues & Volume, By Medicinal materials retail, 2021- 2031F |
6.3.7 Australia Pharmacy Retail Market Revenues & Volume, By Proprietary chinese medicine retail, 2021- 2031F |
7 Australia Pharmacy Retail Market Import-Export Trade Statistics |
7.1 Australia Pharmacy Retail Market Export to Major Countries |
7.2 Australia Pharmacy Retail Market Imports from Major Countries |
8 Australia Pharmacy Retail Market Key Performance Indicators |
8.1 Average prescription fill rate per pharmacy |
8.2 Percentage of revenue from value-added services (e.g., vaccinations, health screenings) |
8.3 Customer satisfaction scores for pharmacy services |
8.4 Percentage of revenue from private label or exclusive products |
8.5 Employee retention rate and training investment |
9 Australia Pharmacy Retail Market - Opportunity Assessment |
9.1 Australia Pharmacy Retail Market Opportunity Assessment, By Type, 2021 & 2031F |
9.2 Australia Pharmacy Retail Market Opportunity Assessment, By Drug Type, 2021 & 2031F |
9.3 Australia Pharmacy Retail Market Opportunity Assessment, By End User, 2021 & 2031F |
10 Australia Pharmacy Retail Market - Competitive Landscape |
10.1 Australia Pharmacy Retail Market Revenue Share, By Companies, 2024 |
10.2 Australia Pharmacy Retail Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here